91 related articles for article (PubMed ID: 968174)
1. Serum levels of 5-hydroxyindole derivates after administration of L-5-hydroxytryptophan ethyl ester.
Korf J; Sebens JB; Venema K; van Praag HM
Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):171-82. PubMed ID: 968174
[TBL] [Abstract][Full Text] [Related]
2. An unexpected effect of L-5 hydroxytryptophan-ethyl-ester combined with a peripheral decarboxylase inhibitor on human serum prolactin.
van Praag HM; Korf J; Lequin RM
Psychopharmacol Commun; 1976; 2(5-6):369-78. PubMed ID: 1088302
[TBL] [Abstract][Full Text] [Related]
3. Brain and peripheral metabolism of 5-hydroxytryptophan-14C following peripheral decarboxylase inhibition.
Warsh JJ; Stancer HC
J Pharmacol Exp Ther; 1976 Jun; 197(3):545-55. PubMed ID: 1084420
[TBL] [Abstract][Full Text] [Related]
4. Measurement of 5-hydroxyindole compounds during L-5-HTP treatment in depressed patients.
Takahashi S; Takahashi R; Masumura I; Miike A
Folia Psychiatr Neurol Jpn; 1976; 30(4):461-73. PubMed ID: 1087913
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic disturbances in autistic disorder: L-5-hydroxytryptophan administration to autistic youngsters increases the blood concentrations of serotonin in patients but not in controls.
Croonenberghs J; Verkerk R; Scharpe S; Deboutte D; Maes M
Life Sci; 2005 Mar; 76(19):2171-83. PubMed ID: 15733932
[TBL] [Abstract][Full Text] [Related]
6. Altered dopamine and serotonin metabolism in the dopamine-denervated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine.
Molina-Holgado E; Dewar KM; Descarries L; Reader TA
J Pharmacol Exp Ther; 1994 Aug; 270(2):713-21. PubMed ID: 8071864
[TBL] [Abstract][Full Text] [Related]
7. Plasma accumulation of metabolism of orally administered single dose L-5-hydroxytryptophan in man.
Magnussen I; Jensen TS; Rand JH; Van Woert MH
Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):184-9. PubMed ID: 6175178
[TBL] [Abstract][Full Text] [Related]
8. Effects of serotonin-active drugs on prolactin secretion in male rats.
Jagiełło-Wójtowicz E; Załuska W; Szponar J; Surmaczyńska B; Wójcicki M; Kleinrok Z
Pol J Pharmacol Pharm; 1988; 40(1):73-80. PubMed ID: 2467272
[TBL] [Abstract][Full Text] [Related]
9. Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron.
Castejon AM; Paez X; Hernandez L; Cubeddu LX
J Pharmacol Exp Ther; 1999 Dec; 291(3):960-6. PubMed ID: 10565811
[TBL] [Abstract][Full Text] [Related]
10. [Changes of plasma serotonin precursor metabolite concentrations in postmenopausal women with hot flushes].
Chen Y; Lü X; Huang Y; Xin X; Ye X
Zhonghua Fu Chan Ke Za Zhi; 2002 Dec; 37(12):726-8. PubMed ID: 12622915
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients.
Mitani H; Shirayama Y; Yamada T; Kawahara R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):531-4. PubMed ID: 16414168
[TBL] [Abstract][Full Text] [Related]
12. L-5-hydroxytryptophan. Correlation between anticonvulsant effect and increases in levels of 5-hydroxyindoles in plasma and brain.
Löscher W; Pagliusi SR; Müller F
Neuropharmacology; 1984 Sep; 23(9):1041-8. PubMed ID: 6083501
[TBL] [Abstract][Full Text] [Related]
13. On the tryptophan-serotonin metabolism in manic-depressive disorders. Changes in plasma 5-HT and 5-HIAA levels and urinary 5-HIAA excretion following oral loading of L-5HTP in patients with depression.
Amamoto T; Sarai K
Hiroshima J Med Sci; 1976 Sep; 25(2-3):135-40. PubMed ID: 1088369
[No Abstract] [Full Text] [Related]
14. Localization and quantification of 5-hydroxytryptophan and serotonin in the central nervous systems of Tritonia and Aplysia.
Fickbohm DJ; Lynn-Bullock CP; Spitzer N; Caldwell HK; Katz PS
J Comp Neurol; 2001 Aug; 437(1):91-105. PubMed ID: 11477599
[TBL] [Abstract][Full Text] [Related]
15. Plasma 5-hydroxytryptamine (5-HT) in migraine during an attack-free period.
Nagata E; Shibata M; Hamada J; Shimizu T; Katoh Y; Gotoh K; Suzuki N
Headache; 2006 Apr; 46(4):592-6. PubMed ID: 16643553
[TBL] [Abstract][Full Text] [Related]
16. [Determination of plasma serotonins level in patients with pregnancy induced hypertension].
Zhao W; Zhao L; Zhao W
Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):406-8. PubMed ID: 11360650
[TBL] [Abstract][Full Text] [Related]
17. Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury.
Christofides J; Bridel M; Egerton M; Mackay GM; Forrest CM; Stoy N; Darlington LG; Stone TW
J Neurochem; 2006 May; 97(4):1078-88. PubMed ID: 16573644
[TBL] [Abstract][Full Text] [Related]
18. Changes in serotonin metabolism may elicit obstructive apnoea in the newborn rat.
Hilaire G; Morin D; Lajard AM; Monteau R
J Physiol; 1993 Jul; 466():367-81. PubMed ID: 7692042
[TBL] [Abstract][Full Text] [Related]
19. The origin of blood 5-hydroxyindoleacetic acid following L-hydrazine-alpha-methyldopa (MK-486).
Warsh JJ; Stancer HC
Eur J Pharmacol; 1975 May; 32(1):128-32. PubMed ID: 1080116
[TBL] [Abstract][Full Text] [Related]
20. Release and metabolism of 5-hydroxytryptamine in the cat spinal cord examined with microdialysis.
Sorkin LS; Hughes MG; Liu D; Willis WD; McAdoo DJ
J Pharmacol Exp Ther; 1991 Apr; 257(1):192-9. PubMed ID: 1708424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
